Qingdao NovelBeam Technology Co.,Ltd. (SHA:688677)

China · Delayed Price · Currency is CNY

50.45

-3.62 (-6.70%)

Nov 13, 2026, 3:00 PM CST

Market Cap	5.93B +3.4%
Revenue (ttm)	637.15M +11.4%
Net Income	146.99M -15.7%
EPS	1.25 -13.8%
Shares Out	117.47M
PE Ratio	40.42
Forward PE	31.34
Dividend	0.60 (1.19%)
Ex-Dividend Date	Jun 10, 2026

Volume	3,925,493
Open	54.59
Previous Close	54.07
Day's Range	50.23 - 55.00
52-Week Range	36.01 - 171.00
Beta	1.07
Analysts	Strong Buy
Price Target	77.07 (+52.77%)
Earnings Date	Oct 24, 2026

About SHA:688677

Qingdao NovelBeam Technology Co.,Ltd. engages in the research and development, production, sales, and service of medical endoscopic instruments and optical products in China and internationally. The company offers IV endoscopic surgery workstation, camera system, LED cold light source, and laparoscope; OV clinic and surgery workstation; and optics products. It also provides endoscope, light source, camera system, surgical imaging system, endoscopic system, and operation room visualization solutions; optical components, optomechanical modules, a... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2003

Employees 1,150

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688677

Full Company Profile

Financial Performance

In 2025, SHA:688677's revenue was 602.61 million, an increase of 36.08% compared to the previous year's 442.83 million. Earnings were 170.74 million, an increase of 26.15%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 688677 stock is "Strong Buy." The 12-month stock price target is ¥77.07, which is an increase of 52.77% from the latest price.

Price Target

¥77.07

(52.77% upside)

Analyst Consensus: Strong Buy

Stock Forecasts